Top 5 Life Science Angel Investors in Belgium in April 2025
A list of 5 angel investors that invest in Life science startups based in Belgium. We rank investors based on the number of investments they made in Life science companies from Belgium. We update this investor list every month.Top 5 Life Science Angel Investors in Belgium in April 2025
Investor | Life Science Belgium investments |
---|---|
Luc Vauterin | 2 |
Pierre Drion | 2 |
Kenneth Buckfire | 1 |
Annie Vereecken | 1 |
Evren Ucok | 1 |
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
Biotech
EdTech
Venture Capital
Sustainability
Organic Food
Social Media
Real Estate
Web3
Big Data
Education
Android
Finance
Video Games
Payments
Art
Publishing
Food and Beverage
Digital Media
Financial Services
Retail
Social Network
Clean Energy
B2B
Franchise
Photography
Infrastructure
Construction
Beauty
Platforms
Mobile Advertising
Recruiting
Local
Biotechnology
Hospitality
Cannabis
Fitness
Travel
eSports
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Legal
Social
CleanTech
Enterprise Software
Mobile Apps
Transportation
InsurTech
Internet
Enterprise
Sports
Medical
LGBT
Email
Wellness
Music
Manufacturing
Mobile
Theatre
Fashion
Oil and Gas
Film
Life Science
Sporting Goods
Non Profit
Renewable Energy
SaaS
Restaurants
Celebrity
Software
Social Impact
Machine Learning
Cryptocurrency
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Oceania
Japan
Sri Lanka
Singapore
Europe
Indonesia
South Africa
Georgia
Vietnam
Ecuador
Bahrain
Faroe Islands
Belize
Egypt
Croatia
Greece
Ghana
Hungary
Finland
LATAM
Estonia
Costa Rica
Czech Republic
Ethiopia
France
Belgium
Hong Kong
Spain
Barbados
Gibraltar
Bermuda
Belarus
Algeria
Chile
Denmark
Bulgaria
Liberia
Armenia
Kuwait
Brazil
Peru
Myanmar
Liechtenstein
Morocco
Africa
Norway
Mexico
Panama
Middle East
Lithuania
Nicaragua
Mali
Qatar
Lebanon
Mauritius
Asia
Philippines
Israel
Jersey
Saudi Arabia
Malaysia
Malta
Italy
Dominican Republic
Tajikistan
Togo
Namibia
Seychelles
Poland
Zimbabwe
Tanzania
Puerto Rico
Serbia
Sweden
Iceland
Senegal
Taiwan
Rwanda
Tunisia
Zambia
Slovenia
Sierra Leone
San Marino
Thailand
Uruguay
Portugal
Uzbekistan
Russian Federation
Turkey
El Salvador
Ukraine
Uganda
Azerbaijan
Venezuela
United Arab Emirates
Nigeria
Jamaica
Honduras
Bolivia
Isle of Man
Bahamas
Luxembourg
Iraq
Pakistan
Albania
Romania
Grenada
Bangladesh
Argentina
Jordan
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Biotech
Health Care
SaaS
Climate
Community
Real Estate
Gaming
Transportation
Publishing
Retail
Platforms
Legal
Payments
Hardware
Proptech
Artificial intelligence
Energy
Media (entertainment)
Construction
Machine Learning
Mobile